JPMorgan stock price rises despite Trump’s $5 billion lawsuit — here’s what investors watch next
22 January 2026
2 mins read

JPMorgan stock price rises despite Trump’s $5 billion lawsuit — here’s what investors watch next

New York, Jan 22, 2026, 17:20 EST — After-hours

  • Shares of JPM climbed during Thursday’s session and stayed close to those gains after hours.
  • President Donald Trump has launched a $5 billion lawsuit targeting JPMorgan and its CEO, Jamie Dimon, accusing them of “debanking.”
  • Traders are focused on legal developments, credit-card rate debates, and the Fed’s meeting coming up next week.

Shares of JPMorgan Chase & Co edged up 0.5% to $303.63 on Thursday, hovering just below their 52-week peak. This came after U.S. President Donald Trump filed a $5 billion lawsuit against the bank and CEO Jamie Dimon, accusing them of politically motivated “debanking.” The suit, lodged in Miami-Dade County’s Florida state court, claims the bank shut down Trump-linked accounts for political reasons. JPMorgan responded by stating it “believe[s] the suit has no merit.” 1

The legal battle is timely, hitting amid a renewed political debate over how banks monitor their clients and sectors. “Debanking”—the broad term for closing accounts or denying services—has turned into a hot-button topic that drags lenders into Washington, regardless of their financial health.

Equity investors face risks beyond just damages or legal expenses. The bigger concern is if this case sparks policy changes affecting how banks handle client risk, set credit prices, or justify closing accounts—areas already burdened by steep compliance costs.

Dimon weighed in this week against a proposed one-year credit card interest rate cap at 10%, calling it an “economic disaster” that would cut off credit for 80% of Americans. Brian Jacobsen, chief economic strategist at Annex Wealth Management, said such a 10% cap is “highly unlikely” to happen anytime soon, since it would need Congress to act. 2

JPMorgan revealed a pensions-tech move that leans toward fee income and product expansion, steering clear of politics. An internal memo seen by Reuters confirmed the bank has wrapped up its acquisition of UK-based WealthOS, a company founded in 2019. Staff from the UK and Sri Lanka are now joining JPMorgan. The bank aims to strengthen its pensions offering through J.P. Morgan Personal Investing using the platform. 3

Late Thursday brought another filing-fueled headline: JPMorgan disclosed that Dimon’s 2025 compensation jumped roughly 10% to $43 million. That breaks down to a $1.5 million base salary plus $41.5 million in incentives. 4

The broader market showed strength. Wall Street’s key indexes ended Thursday up, boosted by tariff relief and positive U.S. economic data. One money manager captured the uncertainty perfectly: “you do not know whether it is Christmas morning or Friday the 13th.” 5

Yet the stock’s steady mood might change if regulators get involved, copycat lawsuits emerge, or major banks find themselves tangled further in the culture-war clash over account access. The credit-card rate debate adds another variable: even stalled legislation can trigger headlines that shake investor confidence in what’s seen as a key profit driver.

Investors are set to focus on initial court developments in Trump’s case and any new hints from Washington about card-rate limits. All eyes are on the Federal Reserve’s Jan. 27–28 meeting, a crucial date for banks closely tied to rate forecasts and funding expenses. 6

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Oracle stock rises after-hours as Stargate loan jitters and FedRAMP push land on traders’ screens
Previous Story

Oracle stock rises after-hours as Stargate loan jitters and FedRAMP push land on traders’ screens

GE Aerospace stock price drops 7% after earnings even as 2026 profit forecast tops estimates
Next Story

GE Aerospace stock price drops 7% after earnings even as 2026 profit forecast tops estimates

Go toTop